Schedule 13G ownership disclosure
Forte Biosciences Inc
COMMON STOCK · CUSIP: 34962G208
Event date: 2025-06-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Federated Hermes, Inc.
Shares: 1,072,233.00 · Class: 8.78%
- Voting Shares Irrevocable Trust
Shares: 1,072,233.00 · Class: 8.78%
- Thomas R. Donahue
Shares: 1,072,233.00 · Class: 8.78%
- Ann C. Donahue
Shares: 1,072,233.00 · Class: 8.78%
- J. Christopher Donahue
Shares: 1,072,233.00 · Class: 8.78%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001623632-25-000782
- Form type
- SCHEDULE 13G
- Filer
- FEDERATED HERMES, INC.
- CIK
- CIK 1056288
- Filed
- Jul 08, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership